Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138502 · ClinicalTrials.gov registry record
Funguria in Hospitalized Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 926
- Enrollment target
NCT00138502: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00138502 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 926 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00138502 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 926 participants
- Enrollment target
Study Summary
The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 926 participants |
| Start Date | 2001-09-17 |
| Est. Completion | 2008-12-08 |
What the finished NCT00138502 record still lists
NCT00138502 is an observational study that tracks outcomes without assigning an intervention. The registered 926 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00138502 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00138502 about?
NCT00138502 is a clinical study titled "Funguria in Hospitalized Patients". The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.
What is the current status of trial NCT00138502?
This trial is currently completed. The enrollment target is 926 participants. The study started on 2001-09-17. Estimated completion is 2008-12-08.
Who is sponsoring clinical trial NCT00138502?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03995082 · 925 participants · NA
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
- NCT06378541 · 928 participants · NA
Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)
- NCT04692493 · 924 participants · Phase 3
Ra-pro Pragmatic Trial
- NCT05656807 · 924 participants · NA
Evaluation of Child Care Staff Weight Management Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI